Patent Application
Utility
App. No. 17/070,173
· Confirmation No. 7850
Naltrexone Long Acting Formulations and Methods of Use
Inventor:
Elliot Ehrich
Applicant:
Alkermes Pharma Ireland Limited
Abandoned -- Incomplete Application (Pre-examination)
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2021-07-13 | ABN |
Abandonment | 2 | View | |
| 2021-05-03 | NT.INC.REPLY |
Notice of Incomplete Reply | 2 | View | |
| 2021-05-03 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2021-04-29 | XT/ |
Extension of Time | 1 | View | |
| 2021-04-29 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2021-04-29 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2020-11-02 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2020-11-02 | NTC.MISS.PRT |
Notice to File Missing Parts | 2 | View | |
| 2020-11-02 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2020-10-14 | PA.. |
Power of Attorney | 1 | View | |
| 2020-10-14 | OATH |
Oath or Declaration filed | 1 | View | |
| 2020-10-14 | LET. |
Miscellaneous Incoming Letter | 2 | View | |
| 2020-10-14 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2020-10-14 | ADS |
Application Data Sheet | 8 | View | |
| 2020-10-14 | ABST |
Abstract | 1 | View | |
| 2020-10-14 | CLM |
Claims | 3 | View | |
| 2020-10-14 | SPEC |
Specification | 27 | View | |
| 2020-10-14 | DRW |
Drawings-only black and white line drawings | 5 | View | |
| 2020-10-14 | LET. |
Miscellaneous Incoming Letter | 1 | View |
Inventors
Elliot Ehrich
Boston, MA
Attorneys & Agents of Record
Classification
USPC
514/282
Prosecution
- Art Unit
- 1629
- Customer No.
- 38421
- Docket No.
- 4165.3010 US11
- Confirmation No.
- 7850
Parent
is a Continuation of
→
App. 16/844,020
Filed 2020-04-09
· Abandoned -- Incomplete Application (Pre-examination)
Parent
is a Continuation of
→
App. 16/656,022
Filed 2019-10-17
· Abandoned -- Incomplete Application (Pre-examination)
Parent
is a Continuation of
→
App. 16/565,907
Filed 2019-09-10
· Expressly Abandoned -- During Examination
Parent
is a Continuation of
→
App. 16/251,542
Filed 2019-01-18
· Abandoned -- Incomplete Application (Pre-examination)
Parent
is a Continuation of
→
App. 16/107,218
Filed 2018-08-21
· Abandoned -- Incomplete Application (Pre-examination)
Parent
is a Continuation of
→
App. 15/486,869
Filed 2017-04-13
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Continuation of
→
App. 15/254,580
Filed 2016-09-01
· Abandoned -- Incomplete Application (Pre-examination)
Parent
is a Continuation of
→
App. 13/871,534
Filed 2013-04-26
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Continuation of
→
App. 13/037,713
Filed 2011-03-01
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Division of
→
App. 11/083,167
· US 7,919,499
Filed 2005-03-17
· Patented Case
Parent
Claims priority from a provisional application
→
App. 60/564,542
Filed 2004-04-22
· Provisional Application Expired
Child
is a Continuation of
→
App. 17/244,110
Filed 2021-04-29
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 18/243,832
Filed 2023-09-08
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 17/540,490
Filed 2021-12-02
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 17/861,575
Filed 2022-07-11
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 18/099,645
· Abandoned -- Incomplete Application (Pre-examination)
No recorded assignments were found for this patent.
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 17/070,173
- Filed
- 2020-10-14
- Art Unit
- 1629
External Links